The Anesthetic and Analgesic Effect of Adjunct Liposomal Bupivacaine in Periodontal Surgical Procedures

NCT07725731 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

58

Enrollment

OTHER

Sponsor class

Conditions

Periodontal Surgery

Interventions

DRUG: 0.5% Bupivacaine HCl
DRUG: Liposomal Bupivacaine (EXPAREL®)/Bupivacaine

Sponsor

The University of Texas Health Science Center at San Antonio